自体血补片胸膜固定术治疗肺叶切除后持续性漏气:多中心回顾性队列研究
该多中心回顾性队列研究纳入2010至2019年间4个中心510例肺叶切除后持续性漏气患者,比较接受自体血补片胸膜固定术(ABPP)与未接受ABPP或其它操作者的结局。倾向性评分匹配后每组109例,ABPP组胸管拔除时间、住院时间和围术期并发症均显著减少,且未增加远期胸膜固定相关并发症,提示ABPP安全有效。
要点
- 肺叶切除后持续性漏气发生率为10%至15%,目前尚无共识管理方案。
- 倾向性评分匹配后ABPP组胸管拔除时间8.12天 vs 9.30天(P=.004),住院时间10天 vs 11天(P=.045)。
- ABPP组围术期并发症6例 vs 17例(P=.015),再次有创操作0例 vs 9例(P=.002),再手术0例 vs 4例(P=.044)。
核心结论
- 自体血补片胸膜固定术治疗肺叶切除后持续性漏气安全有效,可缩短住院时间并提前拔除胸管,且不增加并发症。
研究设计与样本
- 多中心回顾性队列研究,回顾2010年1月至2019年12月4个中心510例肺叶切除后持续性漏气患者的病历资料。
- 按是否接受ABPP分为两组:A组对漏气超过5天者行ABPP,B组除非绝对必要否则不行ABPP或其它操作;经倾向性评分匹配后每组各109例。
主要发现
- 倾向性评分匹配后,ABPP组胸管拔除前天数显著少于对照组(8.12 vs 9.30,P=.004)。
- ABPP组住院时间显著短于对照组(10 vs 11天,P=.045)。
- ABPP组围术期并发症少于对照组(6 vs 17,P=.015)。
- ABPP组接受额外有创操作的比例低于对照组(0 vs 9,P=.002),再手术率也低于对照组(0 vs 4,P=.044)。
- ABPP组无患者出现与胸膜固定术相关的远期并发症。
临床怎么用
- 对于肺叶切除后持续性漏气超过5天的患者,可考虑行自体血补片胸膜固定术以促进胸管拔除、缩短住院时间。
局限性
- 本研究为回顾性队列研究,原文未报告其它局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prolonged air leaks (PAL) complicate 10% to 15% of lung resections, delaying chest tube removal and prolonging length of hospital stay. No consensus exists for managing this common complication, despite favorable results for autologous blood patch pleurodesis (ABPP) in the literature. The aim of this study was to evaluate the effectiveness and safety of ABPP. METHODS: We retrospectively reviewed medical records of 510 patients with PAL after lobectomy in four centers between January 2010 and December 2019. They were divided into two groups: group A consisted of patients who received ABPP for PAL of more than 5 days; and group B was patients for whom no ABPP or other procedure was performed for PAL unless strictly necessary. Propensity score matched analysis was performed, and 109 patients were included in each group. Time to cessation of air leak and chest tube removal, length of hospital stay, reoperation, and complications rate were examined. RESULTS: After the propensity score matching, ABPP significantly reduced the number of days before chest tube removal (8.12 vs 9.30, P = .004), and length of hospital stay (10 vs 11 days, P = .045) with fewer perioperative complications (6 vs 17, P = .015). Furthermore, ABPP was related to lower incidence of any additional invasive procedures (0 vs 9, P = .002) and reoperation (0 vs 4, P = .044). No patient in the ABPP group had long-term complications related to pleurodesis. CONCLUSIONS: Autologous blood patch pleurodesis is safe and effective in reducing length of hospital stay and leads to earlier chest tube removal without increasing complications.
引用
- Campisi A, Dell'Amore A, Gabryel P, et al. Autologous Blood Patch Pleurodesis: A Large Retrospective Multicenter Cohort Study. Ann Thorac Surg. 2021. PMID: 34375648. doi:10.1016/j.athoracsur.2021.06.089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。